Join Swanson Reed, UHY Haines Norton and Wrays for a practical workshop that will focus on the problems that every day companies face in protecting, and claiming incentives for their new products.
You will hear from three industry experts on a range of topics, including tax issues, R&D tax incentives and patent protection.
On conclusion of the presentation, participants will have an opportunity to ask the panel any specific questions in a friendly and constructive forum.
| Time | Presentation | Presenter | |
| 8:30am – 9:00am: | Session 1: Protecting Intellectual Property (IP) | Craig Humphris | |
| 9:00am – 9:30am: | Session 2: IP & Relevant Tax Considerations | Mark Jeffreson | |
| 9:30am – 10:00am: | Session 3: R&D Tax Incentives | David Greatwich | |
| 10:00am – 10:30am: | Session 4: Panel Q&A and Networking Opportunity | ||
| Craig Humphris | Mark Jeffreson | David Greatwich |
![]() |
![]() |
![]() |
| View Craig’s bio | View Mark’s bio | View David’s bio |
Wednesday, 18th June 2014
8:30am – 10:30am
Hilton Adelaide
233 Victoria Square
Adelaide, 5000
Cost: Free!
Register Before: Friday 13th June
Full attendance at this workshop will yield 2 CPE hours towards the Tax Practitioners Board’s (TPB) CPE requirements.
Contact Amy Nolan for more information:
Ph: 08 8121 7850
Mob: 0435 713 493
Are you Eligible to claim R&D? Take our R&D Eligibility Survey and find out.
ASX listed healthcare company provides update on R&D Tax Dispute
In May 2025, Careteq Limited (ASX: CTQ) a clinical healthtech company specialising in medication management and clinical governance solutions announced details of a disputed R&D claim. The May 2025 announcement noted that Careteq: ‘advises that it has been issued with amended assessments from the Australian Taxation Office (ATO) in relation to claims made under the Australian government’s Research and Development Research and Development Tax Incentive (R&D Tax Incentive)for the financial years ended 30 June 2021, 2022 and 2023 (Amended Assessments). The Amended […]
Updated ATO guidance on R&D activities conducted for an associated foreign corporation
The ATO has updated guidance on 13 July 2026 around the provisions for R&D activities conducted for an associated foreign corporation. To be eligible to claim the R&D tax incentive for R&D activities conducted for one or more associated foreign corporations, the following conditions must apply: Each foreign corporation must be a resident of a foreign country that has a double tax agreement with Australia. The R&D activity must be conducted solely in Australia or an external territory of Australia. If the R&D activity is a supporting […]